Pharmacia Italia S.p.a.

Marco Pandolfi

Mario Ungari

Attilio Tomasi

Giuliano Ramella

Stefania Magenes

Ilaria Candiani

Raffaella Budelli

Crystalline form II of cabergoline, a pharmaceutical composition containing it and a process for its preparation are disclosed. The process may comprise crystallization from s solution of raw cabergoline in an organic solvent at low temperatures or submitting to a slurry procedure a mixture of cabergoline forms I and II in a solvent at a temperature below 30&deg; C.

Crystalline form II of cabergoline

Crystalline form VII of cabergoline, a pharmaceutical composition containing it and a process for its preparation are disclosed. The process may comprise a slurry procedure using form I or mixture of forms I and VII of cabergoline in a solvent at a temperature above 30&deg; C.

Crystalline form VII of cabergoline

Crystalline form II of cabergoline, a pharmaceutical composition containing it and a process for its preparation are disclosed. The process may comprise crystallization from a solution of raw cabergoline in an organic solvent at low temperatures or submitting to a slurry procedure a mixture of cabergoline Forms I and II in a solvent at a temperature below about 30&deg; C.

Growing community of inventors

Monza, Italy

Marco Pandolfi